Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers

被引:4
作者
Hannan, C. Jestin [1 ]
Linder, G. [1 ]
Kung, C-H [2 ,3 ]
Johansson, J. [4 ]
Lindblad, M. [2 ]
Hedberg, J. [1 ]
机构
[1] Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden
[2] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
[3] Skelleftea Cty Hosp, Skelleftea, Sweden
[4] Skane Univ Hosp, Lund, Sweden
来源
BJS-BRITISH JOURNAL OF SURGERY | 2020年 / 107卷 / 11期
关键词
DIRECTED ACYCLIC GRAPHS; NEOADJUVANT CHEMORADIOTHERAPY; CURATIVE TREATMENT; SURGICAL-TREATMENT; DIAGNOSIS; CHEMOTHERAPY; PROBABILITY; MANAGEMENT; REGISTER; CARCINOMA;
D O I
10.1002/bjs.11671
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Only around one-quarter of patients with cancer of the oesophagus and the gastro-oesophageal junction (GOJ) undergo surgical resection. This population-based study investigated the rates of treatment with curative intent and resection, and their association with survival. Methods Patients diagnosed with oesophageal and GOJ cancer between 2006 and 2015 in Sweden were identified from the National Register for Oesophageal and Gastric Cancer (NREV). The NREV was cross-linked with several national registries to obtain information on additional exposures. The annual proportion of patients undergoing treatment with curative intent and surgical resection in each county was calculated, and the counties divided into groups with low, intermediate and high rates. Treatment with curative intent was defined as definitive chemoradiation therapy or surgery, with or without neoadjuvant oncological treatment. Overall survival was analysed using a multilevel model based on county of residence at the time of diagnosis. Results Some 5959 patients were included, of whom 1503 (25 center dot 2 per cent) underwent surgery. Median overall survival after diagnosis was 7 center dot 7, 8 center dot 8 and 11 center dot 1 months respectively in counties with low, intermediate and high rates of treatment with curative intent. Corresponding survival times for the surgical resection groups were 7 center dot 4, 9 center dot 3 and 11 center dot 0 months. In the multivariable analysis, a higher rate of treatment with curative intent (time ratio 1 center dot 17, 95 per cent c.i. 1 center dot 05 to 1 center dot 30; P < 0 center dot 001) and a higher resection rate (time ratio 1 center dot 24, 1 center dot 12 to 1 center dot 37; P < 0 center dot 001) were associated with improved survival after adjustment for relevant confounders. Conclusion Patients diagnosed in counties with higher rates of treatment with curative intent and higher rates of surgery had better survival.
引用
收藏
页码:1500 / 1509
页数:10
相关论文
共 50 条
[41]   Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma [J].
Kopsaftis, Zoe ;
Yap, Hooi Shan ;
Tin, Kyi Saw ;
Hnin, Khin ;
Carson-Chahhoud, Kristin, V .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05)
[42]   Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer [J].
Touchefeu, Yann ;
Archambeaud, Isabelle ;
Landi, Bruno ;
Lievre, Astrid ;
Lepere, Celine ;
Rougier, Philippe ;
Mitry, Emmanuel .
DIGESTIVE AND LIVER DISEASE, 2014, 46 (03) :283-286
[43]   Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population [J].
Abbas, M. Nazim ;
Bright, Tim ;
Price, Timothy ;
Karapetis, Christos ;
Thompson, Sarah ;
Connell, Caroline ;
Watson, David ;
Barnes, Mary ;
Bull, Jeff ;
Singhal, Nimit ;
Roy, Amitesh .
ANZ JOURNAL OF SURGERY, 2021, 91 (12) :2675-2682
[44]   Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis [J].
Becher, A. ;
Dent, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) :442-454
[45]   Association of gastro-oesophageal reflux disease and quality of life in patients with chronic rhinosinusitis [J].
Xu, Yang ;
Yang, Wen ;
Song, Yao ;
Cheng, Danni ;
Cao, Min ;
Huang, Jingyue ;
Ren, Jianjun ;
Lee, Jong Wook ;
Hueniken, Katrina ;
Chen, Yao ;
Brown, Catherine ;
Zhang, Yuke ;
Qiu, Ke ;
Xu, Wei ;
Zhao, Yu ;
Liu, Geoffrey .
ACTA OTORHINOLARYNGOLOGICA ITALICA, 2021, 41 (05) :450-460
[46]   Peri-operative chemotherapy versus preoperative chemoradiotherapy in treatment of gastro-oesophageal junctional adenocarcinomas: A 10-year cohort study [J].
Elshaer, Ahmed Mohammed ;
Wijeyaratne, Manuk ;
Higgs, S. M. ;
Hornby, S. T. ;
Dwerryhouse, S. J. .
EJSO, 2023, 49 (10)
[47]   Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis [J].
Molina-Infante, Javier ;
van Rhijn, Bram D. .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (05) :749-758
[48]   Protective Mechanisms of Liquid Formulations for Gastro-Oesophageal Reflux Disease in a Human Reconstructed Oesophageal Epithelium Model [J].
Ceriotti, Laura ;
Buratti, Paolo ;
Corazziari, Enrico Stefano ;
Meloni, Marisa .
MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2022, 15 :143-152
[49]   Gastro-oesophageal reflux disease in 20 dogs (2012 to 2014) [J].
Muenster, M. ;
Hoerauf, A. ;
Vieth, M. .
JOURNAL OF SMALL ANIMAL PRACTICE, 2017, 58 (05) :276-283
[50]   Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease [J].
Jonasson, C. ;
Wernersson, B. ;
Hoff, D. A. L. ;
Hatlebakk, J. G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (05) :564-572